Semaglutide: A Promising Treatment for Alcohol Use Disorder – INSCMagazine
Semaglutide, a GLP-1 receptor agonist initially approved for type 2 diabetes and later for weight management, is now showing potential in treating ...
Condie Carmack
Novo Nordisk Launches National “My Ozempic® Era” Campaign Celebrating Stories of …
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood ...
Low-carb, low-fibre diets could raise risks of colon cancer – Toronto Star
Numerous studies have shown that a diet high in sugar and fat — a so-called “Western-style diet” — is linked to colorectal cancer, as well as obesity ...
Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer
... obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or ...
Tesla, Broadcom, Strategy, Coinbase, Robinhood: Stocks to watch today – Quartz
Eli Lilly wants to replace Zepbound with an even stronger weight loss drug. Nvidia's record earnings reveal just 3 customers make up 30% of revenue.
Semaglutide API Market, Global Outlook and Forecast 2024-2030 – WhaTech
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for the treatment of type 2 diabetes and obesity. The growing ...
Nutrigenomics Market Size, Share and Trends 2025 to 2034 – Precedence Research
... cancer, obesity, and cardiovascular diseases. North America has a ... Obesity is a primary application area for nutrigenomics. The obesity ...
ACTION Malaysia—perception and barriers to obesity management among people with …
The Awareness, Care, and Treatment in Obesity maNagement in the Asia Pacific region ... 79%), cancer (72% vs. 68%), or stroke (68% vs. 74%) (Fig ...
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Many employers and insurers are scaling back coverage of Wegovy and Zepbound, and a key government program, Medicare, doesn't cover the drugs for ...
Diabetes Dialogue: News and Updates in Diabetes Care from February 2025 – HCPLive
... (Zepbound) single-dose vials and reduced pricing as well as the FDA ... On February 25, 2025, Eli Lilly and Company announced the launch of 7.5 mg and 10 ...